Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Customized laser skin treatment for superficial tumors, hair removal, Port-Wine Stain and other superficial vascular disorders. More
AS-22 is a hypertonic, non-specific MMP-inhibiting, hydrating & cleaning solution to treat bedsores, diabetic ulcers, and venous leg ulcers. Reduces pain and promotes fast healing, even in case of refractory wounds More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 72 pages - $1,495
Mar 2011 - 53 pages - $500
Nov 2010 - 590 pages - $1,495
Nov 2010 - 106 pages - $1,495
Jun 2011 - 29 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Mar 2011 - 23 pages - $1,000
May 2011 - 36 pages - $1,000
Mar 2011 - 31 pages - $1,000
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us